Ania Jastreboff
Ania Jastreboff is a prominent Yale University professor and researcher in the field of obesity and metabolic disorders. She is known for her groundbreaking work in developing and studying new weight loss medications, including Retatrutid. Her recent presentation at an obesity conference in Venice highlighted the impressive results of her study, which showed that participants lost an average of 24.2% of their body weight over 48 weeks, sparking interest in new treatment options for obesity.
Not in the pool (under ¢1).
Recent news mentions
Ania Jastreboff is the director of the Obesity Research Center at Yale and the principal investigator studying retatrutida for Eli Lilly.
pacientes bajan demasiado de peso, se asustan y los dejan
Argentina· 2026-02-21
Ania Jastreboff is the director of the Yale Obesity Research Center and the lead author of a 2023 study.
Ερχεται η νέα γενιά του Ozempic
Greece· 2025-11-28
Ania Jastreboff is a Yale professor who led the phase 2 study on the latest type of weight loss medication, Retatrutid.
En slankeoperasjon kan være bedre enn slankemedisiner
Norway· 2025-06-23Ania Jastreboff is a Yale professor who presented results from a study on a new type of weight loss medication.
24 prosent ned i vekt på 48 uker. Nye slankemedisiner gir forbløffende resultater.Norway· 2025-05-25Ania Jastreboff is a Yale professor who presented results from a study on a new type of weight loss medication.
24 prosent ned i vekt på 48 uker. Nye slankemedisiner gir forbløffende resultater.Norway· 2025-05-25